Amgen to cut small number of Horizon jobs in Ireland
Amgen has about 26,700 staff worldwide following the Horizon acquisition
Amgen will lay off a small number employees from Dublin-headquartered Horizon Therapeutics next year, after closing its $27.8bn (€26.3bn) acquisition of the rare-disease drugmaker earlier this month.
More than 80% of Horizon employees were placed in roles at Amgen, according to a spokesperson for the biotechnology company. None of the laid-off employees have separation dates this year and all cuts would be in the US or Ireland, they said. It is understood approximately 22 workers in Ireland will be impacted.




